시험참여신청

㈜프리더마피부임상연구원

시험참여신청

시험명
[Oneday] Comparative Study of Skin Characteristics and Blood Biomarkers Associated with Aging
시험기간
2026-11-02 ~ 2026-11-12
참여신청기간
2026-10-21 ~ 2026-11-12 (08:30,09:00,09:30,10:00,10:30,13:30,14:00)
모집대상
Caucasian female volunteers aged 20–39 years
모집인원
20명
시험참여비
50,000원
시험장소
시험장소: ㈜프리더마피부임상연구원
담당자
㈜프리더마피부임상연구원
선정기준
제외기준
시험방법

1. Study Title

Comparative Study of Skin Characteristics and Blood Biomarkers Associated with Aging


2. Eligibility Criteria

① Caucasian female volunteers aged 20–39 years who meet the inclusion criteria and do not meet any of the exclusion criteria

② Volunteers who are able and willing to undergo blood collection

③ Volunteers with no abnormal skin conditions on the face, such as wounds, scars, tattoos, or atopic dermatitis

 (In particular, if you have even a minor skin condition on your cheeks, a photo must be provided for confirmation.)

④ Healthy volunteers with no acute or chronic medical conditions, including skin diseases

⑤ Volunteers who have not undergone laser treatment, professional skin care treatments, tanning, or similar procedures within the past month


3. Study Duration and Visit Information

- Visit: 1 visit (approx. 2 hours)

- Procedures: Facial photography, skin measurements & blood collection (Fasting: Not required)

- Dates: Nov. 2 (Mon), 10 (Tue), 11 (Wed), or 12 (Thu), 2026


★New Participant Referral Bonus: + KRW 30,000

★First-Time Visitor Bonus: + KRW 20,000

기타 주의사항

[Anticipated Adverse Reactions and Side Effects]

The test product has been manufactured in compliance with applicable cosmetic laws and regulations, and the likelihood of adverse reactions occurring under normal conditions of use is expected to be low.

However, the possibility of adverse reactions, such as skin irritation (stinging, burning sensation, etc.), erythema, itching, and rash, cannot be completely ruled out depending on individual skin characteristics and sensitivity.

If an adverse reaction occurs during the clinical study, the principal investigator or study personnel will assess the severity of the adverse reaction and its relationship to the test product. If necessary, use of the test product will be discontinued, and appropriate medical measures will be taken.

In addition, if new information regarding the safety of the test product is identified or obtained during the clinical study, such information will be provided to the subjects or their legally authorized representatives without delay.




참여신청

* 내 참여신청 목록은 메뉴 상단의 [마이페이지]에서 확인 가능합니다.